CFR section

21 CFR 50.55(a): Requirements for permission by parents or guardians and for assent by children

PART 50-PROTECTION OF HUMAN SUBJECTS · Subpart D-Additional Safeguards for Children in Clinical Investigations

Key facts

Citation 21 CFR 50.55(a)
Section Requirements for permission by parents or guardians and for assent by children
Part PART 50-PROTECTION OF HUMAN SUBJECTS
Subpart Subpart D-Additional Safeguards for Children in Clinical Investigations
Subchapter 21 CFR A General
Product types cited General
Regulation text (excerpt) (a) In addition to the determinations required under other applicable sections of this subpart D, the IRB must determine that adequate provisions are made for soliciting the assent of the children when in the judgment of the IRB the children are capable of providing assent.

At a glance

  • 1–9 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA